HIV-1 dual infection is associated with faster CD4 + T-cell decline in a cohort of men with primary HIV infection

Clinical Infectious Diseases

Volumn 54, Issue 4, 2012, Pages 539-547

  Cornelissen, Marion ^a   Pasternak, Alexander O ^a   Grijsen, Marlous L ^b   Zorgdrager, Fokla ^a   Bakker, Margreet ^a   Blom, Petra ^a   Prins, Jan M ^b   Jurriaans, Suzanne ^a   Van Der Kuyl, Antoinette C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Division of Infectious Diseases   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; HLA B ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; PHYLOGENETIC TREE; PRIMARY INFECTION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SUPERINFECTION; THERAPY DELAY; VIRUS LOAD; VIRUS STRAIN;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; COINFECTION; DISEASE PROGRESSION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 84856733514     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir849     Document Type: Article

References (37)

1. Ramos A, Hu DJ, Nguyen L, et al. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002; 76:7444-52. (Pubitemid 34760966)
2. Jost S, BernardMC, Kaiser L, et al. A patient with HIV-1 superinfection. N Engl J Med 2002; 347:731-6. (Pubitemid 35203904)
3. Altfeld M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD81 T-cell responses containing replication of the primary virus. Nature 2002; 420:434-9. (Pubitemid 35415656)
4. Van der Kuyl AC, Kozaczynska K, Van den Burg R, et al. Triple HIV-1 infection. N Engl J Med 2005; 352:2557-9.
5. Lamine A, Caumont-Sarcos A, Chaix ML, et al. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS 2007; 21:1043-5. (Pubitemid 46684337)
6. Rachinger A, Navis M, van Assen S, Groeneveld PH, Schuitemaker H. Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection. Clin Infect Dis 2008; 47:e86-9.
7. Clerc O, Colombo S, Yerly S, Telenti A, Cavassini M. HIV-1 elite controllers: beware of super-infections. J Clin Virol 2010; 47:376-8.
8. Afkhami-Goli A, Liu SH, Zhu Y, Antony JM, Arab H, Power C. Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence. J Neurovirol 2009; 15:1-14.
9. Nowak MA, May RM. Superinfection and the evolution of parasite virulence. Proc Biol Sci 1994; 255:81-9.
10. Fung IC, Gambhir M, van Sighem A, de Wolf F, Garnett GP. Superinfection with a heterologous HIV strain per se does not lead to faster progression. Math Biosci 2010; 224:1-9.
11. Fernandez Larrosa PN, Ceballos A, Andreani G,Marquina S,Martinez PL, Rabinovich RD. Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1. Arch Virol 2006; 151:651-62.
12. van der Kuyl AC, Kozaczynska K, Arien KK, et al. Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness. Retrovirology 2010; 7:60.
13. van der Kuyl AC, Cornelissen M. Identifying HIV-1 dual infections. Retrovirology 2007; 4:67.
14. Gottlieb GS, Nickle DC, Jensen MA, et al. Dual HIV-1 infection associated with rapid disease progression. Lancet 2004; 363:619-22. (Pubitemid 38264182)
15. Gali Y, Berkhout B, Vanham G, Bakker M, Back NK, Arien KK. Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort. Virology 2007; 364:140-6. (Pubitemid 46829281)
16. Kawashima Y, Pfafferott K, Frater J, et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009; 458:641-5.
17. Cornelissen M, Hoogland FM, Back NK, et al. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands. AIDS 2009; 23:1495-500.
18. Bunnik EM, Euler Z, Welkers MR, et al. Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level. Nat Med 2010; 16:995-7.
19. Steingrover R, Pogany K, Fernandez GE, et al. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. AIDS 2008; 22:1583-8.
20. Roda Husman AM, Koot M, Cornelissen M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997; 127:882-90. (Pubitemid 27490625)
21. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495-503. (Pubitemid 20078123)
22. van der Kuyl AC, Jurriaans S, Back NK, et al. Unusual cluster of HIV type 1 dual infections in Groningen, The Netherlands. AIDS Res Hum Retroviruses 2011; 27:429-33.
23. BioEdit sequence alignment editor version 7.0.9. Available at: www.mbio.ncsu.edu/BioEdit/bioedit.html. Accessed 20 January 2011.
24. MEGA 5 software package. Available at: www.megasoftware.net. Accessed 8 February 2011.
25. MrBayes 3.1. Available at: http://mrbayes.net. Accessed 15 September 2010.
26. Piantadosi A, Ngayo MO, Chohan B, Overbaugh J. Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection. AIDS Res Hum Retroviruses 2008; 24:1221.
27. Geno2pheno coreceptor prediction algorithm. Available at: http://coreceptor.bioinf.mpi-inf.mpg.de/index.php. Accessed 19 May 2011.
28. PASW Statistics 18. Available at: http://www.spss.com. Accessed 31 January 2011.
29. GraphPad Prism 5.01. Available at: http://www.graphpad.com. Accessed 31 January 2011.
30. Goulder PJ, Watkins DI. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8:619-30.
31. Cornelissen M, Jurriaans S, Kozaczynska K, et al. Routine HIV-1 genotyping as a tool to identify dual infections. AIDS 2007; 21:807-11. (Pubitemid 46573152)
32. Jurriaans S, Kozaczynska K, Zorgdrager F, et al. A sudden rise in viral load is infrequently associated with HIV-1 superinfection. J Acquir Immune Defic Syndr 2008; 47:69-73. (Pubitemid 351619371)
33. Los Alamos National Laboratory HIV Databases. Available at: http://hiv-web.lanl.gov. Accessed 3 March 2011.
34. Sing T, Low AJ, Beerenwinkel N, et al. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther 2007; 12:1097-106. (Pubitemid 350114990)
35. Carrillo FY, Sanjuan R, Moya A, Cuevas JM. The effect of co-and superinfection on the adaptive dynamics of vesicular stomatitis virus. Infect Genet Evol 2007; 7:69-73. (Pubitemid 44858296)
36. Smith DE, Walker BD, Cooper DA, Rosenberg ES, Kaldor JM. Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS 2004; 18:709-18. (Pubitemid 38534999)
37. Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis 2010; 202(Suppl 2):S278-88.